Dr. Michael Lairmore, professor and associate dean of research and graduate studies, has been appointed the associate director for Shared Resources at the Ohio State University Comprehensive Cancer Center (OSUCCC).

A drug currently approved for osteoporosis treatment has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as an important supplemental therapy in patients with head and neck cancers that erode bone. Dr. Tom Rosol, professor in the department of veterinary biosciences, was the principle investigator in the Ohio State study. The drug treatment also was associated with smaller tumors – an unexpected result. The drug, zoledronic acid, is known by the brand name Zometa.

The College of Veterinary Medicine partners with the College of Public Health to offer the country's only Veterinary Public Health specialization towards the Master of Public Health degree. With the realization that nearly 70 percent of emerging diseases are likely to be zoonotic, the MPH-VPH degree was developed to prepare public health professionals to better protect the communities they serve. The program is open to veterinarians, as well as other professionals, including students with science backgrounds interested in public health.

Dr. John Hubbell, professor of veterinary anesthesiology and equine section head, was recently interviewed at the American Association of Equine Practitioners (AAEP) Annual Convention and Trade Show. To watch his interview on sedatives and anesthetics in horses, click here.